Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells

Marta Osrodek, 1 Michal Rozanski, 1, 2 Malgorzata Czyz 1 1Department of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland; 2Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, Lodz, PolandCorrespondence: Malgorzata CzyzDepartment...

Full description

Bibliographic Details
Main Authors: Osrodek M, Rozanski M, Czyz M
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Cancer Management and Research
Subjects:
brafv600
ngfr
targeted therapy
Online Access:https://www.dovepress.com/insulin-reduces-the-efficacy-of-vemurafenib-and-trametinib-in-melanoma-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/insulin-reduces-the-efficacy-of-vemurafenib-and-trametinib-in-melanoma-peer-reviewed-article-CMAR

Similar Items